ArticleCureus2025
Severe Pediatric Arterial Thrombosis in Antiphospholipid Syndrome and Systemic Lupus Erythematosus: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a chronic, multisystem immune-mediated disease that can affect any organ system. One of its most significant complications is antiphospholipid syndrome (APS), an autoimmune disorder characterized by thrombosis, which typically presents with venous thrombosis in children. We report a 14-year-old previously healthy girl presenting with progressive right foot cyanosis and ulcerative lesions. Examination revealed digital necrosis, absent distal pulses, and delayed capillary refill. Laboratory findings included elevated antiphospholipid antibodies (aPLs), positive antinuclear antibodies (ANAs), hypocomplementemia, prolonged activated partial thromboplastin time (aPTT), and a reactive Venereal Disease Research Laboratory (VDRL) test. Imaging confirmed occlusion of the anterior tibial and peroneal arteries. She was diagnosed with critical limb ischemia due to APS secondary to SLE. Treatment with intravenous methylprednisolone, anticoagulation, antiplatelet agents, and vasoprotective therapy led to significant improvement, avoiding surgical intervention. APS secondary to SLE is uncommon in pediatric patients, and arterial thrombosis is an especially rare initial manifestation. Juvenile SLE often presents with non-specific symptoms such as arthralgias, headache, fever, and weight loss, which were absent in our patient. Instead, initial symptoms included intermittent claudication-like pain and digital necrosis, likely resulting from endothelial cell proliferation, intimal hyperplasia, endothelial dysfunction, platelet activation, and complement consumption, leading to progressive luminal narrowing and thrombosis. The lack of validated pediatric classification criteria for APS secondary to SLE complicates management decisions. This case underscores the importance of early recognition and prompt initiation of anticoagulation, immunosuppression, and vasoprotective therapy to prevent irreversible tissue damage and the need for surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.